Richard Trohman to Risk Assessment
This is a "connection" page, showing publications Richard Trohman has written about Risk Assessment.
Connection Strength
0.901
-
Usefulness of transesophageal echocardiography to confirm clinical utility of CHA2DS2-VASc and CHADS2 scores in atrial flutter. Am J Cardiol. 2012 Feb 15; 109(4):550-5.
Score: 0.334
-
Supplemental Radiofrequency Ablation After Acutely Unsuccessful Cryoballoon Pulmonary Vein Isolation is Associated With Increased Risk of Recurrent Atrial Fibrillation. J Am Heart Assoc. 2020 05 18; 9(10):e015979.
Score: 0.150
-
Meta-analysis of pulmonary vein isolation ablation for atrial fibrillation conventional vs low- and zero-fluoroscopy approaches. J Cardiovasc Electrophysiol. 2020 06; 31(6):1403-1412.
Score: 0.149
-
Amiodarone and thyroid physiology, pathophysiology, diagnosis and management. Trends Cardiovasc Med. 2019 07; 29(5):285-295.
Score: 0.134
-
Reassessing Risk Factors for High Defibrillation Threshold: The EF-SAGA Risk Score and Implications for Device Testing. Pacing Clin Electrophysiol. 2016 May; 39(5):483-9.
Score: 0.113
-
Safety of endoscopic procedures after acute myocardial infarction: a systematic review. Cardiol J. 2012; 19(5):447-52.
Score: 0.021